Evidence map›Paper›PMID 12362031›Full record

ArticleJournal of medical genetics2002

Genetic testing and genetic counselling in hypertrophic cardiomyopathy: the French experience.

P Charron, D Héron, M Gargiulo, P Richard, O Dubourg, M Desnos, J B Bouhour, J Feingold, L Carrier, B Hainque and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of medical genetics, 2002. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
3.5field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 77 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Comparing test-specific distress of susceptibility versus deterministic genetic testing for Alzheimer's disease.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2008
    Trial
  4. Article
  5. Article
  6. Article
  7. A Person-Centered Approach to Cardiovascular Genetic Testing.Cold Spring Harbor perspectives in medicine · 2020
    Review
  8. Article
  9. Genetics of paediatric cardiomyopathies.Current opinion in pediatrics · 2017
    Review
  10. Heritable pulmonary hypertension: from bench to bedside.European respiratory review : an official journal of the European Respiratory Society · 2017
    Review
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Hypertrophic cardiomyopathy.Heart failure clinics · 2010
    Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 6 institutions in 1 country.

P CharronService de Cardiologie, Hôpital Pitié-Salpêtriére, Paris, France. pcharron@infobiogen.fr
D Héron
M Gargiulo
P Richard
O Dubourg
M Desnos
J B Bouhour
J Feingold
L Carrier
B Hainque
K Schwartz
M Komajda
Sorbonne Université · FRInstitut de Recherche en Informatique Fondamentale · FRPitié-Salpêtrière Hospital · FRHôpital Ambroise-Paré · FRHôpital Européen Georges-Pompidou · FRHôpital Laennec · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsA major breakthrough in the molecular genetics of hypertrophic cardiomyopathy (HCM) has made genetic testing now available in clinical practice, raising new questions about its implications, potential benefits, and the organisation of the procedure. The aim of this work was (1) to discuss the different questions related to genetic testing in HCM, and propose guidelines for the different situations, (2) to report our preliminary experience with a specific procedure. METHODS AND

resultsThe main questions asked by patients and relatives concern presymptomatic diagnosis and prenatal counselling/diagnosis, while clinicians sometimes discuss diagnostic and prognostic testing. To take into account the complex medical and psychological implications of this new approach, we developed a specific, multidisciplinary, and multiple step procedure, including a cardiologist, a geneticist, and a psychologist. Seventy subjects were examined, including (1) 29 adults for presymptomatic diagnosis (of whom 10 left the procedure after the first visit and 19 continued, among whom six had a mutation and two experienced negative psychological impact, observed during follow up), (2) nine couples of parents for presymptomatic diagnosis in their children (the procedure was stopped after the first visit in eight and continued in one), (3) 22 couples for prenatal counselling (no prenatal genetic testing was asked for after the first visit), and (4) 10 subjects for diagnostic testing. We decided to perform no prognostic testing.

conclusionOur preliminary experience confirms the complexity of the situation and suggests the necessity for a specific procedure to ensure good practice in genetic testing of HCM.

Indexed as

AdolescentAdultAgedCardiomyopathy, HypertrophicFemaleFranceGenetic CounselingGenetic Predisposition to DiseaseGenetic TestingHumansMaleMiddle AgedPractice Guidelines as TopicPrenatal DiagnosisPrognosis

Identifiers

PMID12362031
PMCPMC1735000
OpenAlexW2109421439

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.